Diseases, Conditions, Syndromes

A novel tuberculosis regimen shortens treatment course for patients

Tuberculosis (TB) is a deadly infection that occurs in every part of the world. The standard treatment for TB, a six-month multidrug regimen, has not changed in more than 40 years. Patients can find it difficult to complete ...

Diseases, Conditions, Syndromes

As COVID rages, world risks losing TB gains

In the year since COVID-19 flipped the world on its head, diagnosis and treatment of another serious lung disease—tuberculosis—has plummeted, leaving experts fearful that progress in tackling that pandemic will be lost.

Diseases, Conditions, Syndromes

New animal model shows effective treatment for latent tuberculosis

A major goal of tuberculosis (TB) research is to find a way to treat people with the latent (or inactive) form of the disease to keep them from developing symptomatic TB. A breakthrough study using a new animal model developed ...

Medications

FDA approves drug for most deadly form of tuberculosis

(HealthDay)—A new drug has been approved as part of a powerful, three-pronged treatment regimen for the most deadly strain of tuberculosis, the U.S. Food and Drug Administration announced Wednesday.

Medical research

Peptide derived from fungi kills TB bacteria

The discovery of the peptide as a possible future antibiotic was made by researchers who screened different antimicrobial peptides' ability to prevent the growth of Mycobacterium tuberculosis. The peptide they found comes ...

Diseases, Conditions, Syndromes

New tuberculosis drug may shorten treatment time for patients

A new experimental antibiotic for tuberculosis has been shown to be more effective against TB than isoniazid, a decades-old drug which is currently one of the standard treatments. In mouse studies, the new drug showed a much ...

page 3 from 9